Boehringer launches first direct thrombin inhibitor: dabigatran (Pradaxa)
- PMID: 20532462
- PMCID: PMC5592318
Boehringer launches first direct thrombin inhibitor: dabigatran (Pradaxa)
Similar articles
-
Dabigatran etexilate for prevention of venous thromboembolism.Thromb Haemost. 2009 Jan;101(1):2-4. Thromb Haemost. 2009. PMID: 19132179 No abstract available.
-
[Dabigatran: a new therapeutic option for therapy and prophylaxis of thromboembolic diseases?].Dtsch Med Wochenschr. 2010 Feb;135(6):256-9. doi: 10.1055/s-0030-1247864. Epub 2010 Jan 26. Dtsch Med Wochenschr. 2010. PMID: 20104442 Review. German. No abstract available.
-
Oral thrombin inhibitor dabigatran etexilate vs North American enoxaparin regimen for prevention of venous thromboembolism after knee arthroplasty surgery.J Arthroplasty. 2009 Jan;24(1):1-9. doi: 10.1016/j.arth.2008.01.132. Epub 2008 Apr 14. J Arthroplasty. 2009. PMID: 18534438 Clinical Trial.
-
Oral antithrombotic inhibitors: dabigatran etexilate, meeting an unmet need?Clin Appl Thromb Hemost. 2009 Sep-Oct;15 Suppl 1:5S-8S. doi: 10.1177/1076029609344427. Epub 2009 Aug 24. Clin Appl Thromb Hemost. 2009. PMID: 19706619
-
Dabigatran etexilate: future directions in anticoagulant treatment.Clin Appl Thromb Hemost. 2009 Sep-Oct;15 Suppl 1:32S-41S. doi: 10.1177/1076029609344199. Epub 2009 Aug 13. Clin Appl Thromb Hemost. 2009. PMID: 19679590 Review.
Cited by
-
Anti-thrombotic trials in atrial fibrillation, the RELY study.Cardiovasc J Afr. 2010 Sep-Oct;21(5):299. Cardiovasc J Afr. 2010. PMID: 20972524 Free PMC article. No abstract available.
References
-
- Cohen AT. et al. Thromb Haemost. 2009;98(4):756–764. - PubMed
-
- Memtsoudis SG. et al. J Arthroplasty. 2010;25(1):19–26. - PubMed
-
- Sweetland S. et al. Br Med J. 2009;339 doi10.1136/bmjb4583.
-
- Warwick DJ, Whithouse S. J Bone Joint Surg. 1997;79-B:780–786. - PubMed
-
- Geerts WH. et al. J Bone Joint Surg. 2008;1336(Suppl):3815–4535.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical